Blood Purification Equipment Market (By Type: Dialysis, CRRT, Hemoperfusion, Others; By Product: Portable, Stationary; By Application: Acute Kidney Injury, Infectious Diseases, Sepsis, Renal Diseases, COVID-19, Others; By End User: Hospitals and Clinics, Dialysis Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
The global blood purification equipment market size was estimated at USD 17.29 billion in 2022 and is projected to hit around USD 31.11 billion by 2032, growing at a CAGR of 6.1% during the forecast period from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The blood purification technique involves withdrawing blood from the patient's body into equipment to extract all the impurities and pump it back into the body. Blood purification plays an extremely important part in various kidney and blood-related problems. Due to the high cost of the equipment and the risk which are associated with the blood purification procedure the use of these devices may hinder the growth of the blood purification equipment market in the future
During the pandemic due to a nationwide lockdown and restrictions on movement the blood purification equipment market was also affected. This industry faced challenges of the demand and supply of blood purification components and other products related to the functioning of the equipment. Define availability of human resources and interrupted supply chain activities negatively impacted the market growth.
Various advancements in dialysis and filtration procedures which are coupled with absorption procedures have led to the growth of this market. The blood purification equipment market it's seeing growth due to the adoption of these equipment in various critical treatments. Blood purification devices are majorly used in renal or organ failures, plasmapheresis, and immune metabolic disorders. As there is an increase in the prevailing metabolic and immune disorders like kidney failure, increase in diabetes and hypertension, under increasing geriatric population across the nations which are extremely susceptible to the diseases related to kidneys are the major reasons which are impelling the growth of the blood purification equipment market. Various technological advancements which are associated with the blood purification technique remove further help in the growth of the market during the coming years.
Blood purification therapies are extremely efficient for the fast and direct removal of pathogenic agents and these techniques will be adopted across many nations in the world. The advancements in the techniques like bioseparation techniques, filtration, adsorption, and dialysis are the factors that are expected to provide a good boost to the expansion of the blood purification equipment market in the future. Currently, blood purification therapy is used for three major reasons plasmapheresis, life support for organ failures, and metabolic disorders.
Report Coverage | Details |
Market Size in 2023 | USD 18.26 Billion |
Market Size by 2032 | USD 31.11 Billion |
Growth Rate from 2023 to 2032 | CAGR of 6.1% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered |
|
Regions Covered |
|
Drivers
The development of advanced equipment is driving the market at a tremendous pace. Emerging technologies are helping to provide faster and more accurate therapeutics to the patient. The growing number of R&D activities taking place are also helping the market to grow. An increasing number of patients with acute and chronic kidney diseases also proves to be a driving force for the market during the forecast period. Advanced equipment providing faster and safer blood purification procedures are helping the market to show sufficient growth.
Restraints
COVID-19 will negatively impact market growth during the pandemic. Reduction in the number of dialysis and other accessories healthcare services hampered the growth of the market, thus a decline was seen during the pandemic. The high cost associated with dialysis procedures also hampers market growth, especially in developing and underdeveloped countries. The lower socioeconomic status of the population restricts market growth to a great extent. The lack of healthcare facilities and dialysis centers in the rural region leads to a loss of potential patient base leading to a decline of the blood purification equipment market.
Opportunities
A higher geriatric population provides a higher number of patients with acute and chronic kidney diseases and kidney failure cases. This in turn helps the market to find an opportunity to grow during the forecast period. Increasing health awareness among the people also has proved to be a boon for the growth of the market. Better healthcare and reimbursement facilities also encourages the population to opt for advanced technological procedures.
Challenges
The lack of healthcare facilities in developing and underdeveloped countries proves to be a challenge for the growth of the market. Due to the growing health awareness among people, the side effects associated with the purification procedures are highlighted which hinders the market growth. The high cost which people have to bare in order to the advantage of these facilities also discourages market growth.
On the basis of the type, the dialysis segment holds the largest market share, and increased inquiry attic populations across developing as well as developed nations with increased risks related to the kidneys or other organs are driving the market growth across the globe. Dialysis is an extremely efficient technique used by many doctors and preferred by many patients. There is increased adoption of blood purification equipment as an increasing number of kidney failures across the world. There is a growing preference among consumers to receive dialysis treatment through dialysis centers. Even though dialysis treatment takes a lot of time and patience spend most of their time in the centers where the dialysis sessions are carried out the number of dialysis patients is still expected to grow for this treatment as it is extremely efficient and will increase in the next year.
On the basis of the product type, the portable segment accounted for more than 80% of revenue share in 2022 and is expected to see good growth during the forecast period. This segment shall dominate the global blood purification equipment market till the year 2032. As these equipment do not occupy a lot of space and they simplify the ease of movement especially in the case of critical care units therefore the market for portable devices is expected to grow during the forecast period. These are the widely preferred devices by healthcare professionals in order to treat their patients.
On the basis of application, the renal disease segment is expected to have the highest revenue during the forecast. Due to increasing incidences of renal disorders across the globe. It is stupid that about 13.3 million cases of acute kidney injury are tracked each year and around 1.7 million deaths occurred due to it. This data was published by the International Society of nephrology in the year 2022. The increasing number of kidney failures or kidney diseases which are leading to the death of a large number of the population has greatly stimulated the demand for blood purification techniques and dialysis treatment across the globe. This technique helps in restoring the metabolism in blood and decreases the toxic content which is expected to drive the growth of the blood purification equipment market during the forecast period.
You put the increase in various kidney diseases and the surge in the geriatric population in America the demand for dialysis is higher in this region. North America is expected to hold a dominant position during the forecast period as there is great availability of varied technologically advanced equipment for critical care units, awareness about the flood certification process amongst the population, and uh health care system which is extremely well established in this region. The Pacific region also has a great opportunity for growth during the forecast period. This region provides opportunities for the growth of the blood purification equipment market as it has a large population with several chronic and lifestyle disorders.
Due to various chronic and lifestyle conditions like diabetes, hypertension, and autoimmune diseases Are all creating a demand for these equipment in many developing countries in the Asia Pacific region the demand for these devices is projected to grow in the coming years. D Asia Pacific region is expected to outgrow the American and the European countries. There are a large number of people with kidney-related disorders that are undiagnosed in this region.
Segments Covered in the Report
By Type
By Product
By Application
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Purification Equipment Market
5.1. COVID-19 Landscape: Blood Purification Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Purification Equipment Market, By Type
8.1. Blood Purification Equipment Market, by Type, 2023-2032
8.1.1. Dialysis
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. CRRT
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Hemoperfusion
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Others (plasma exchange, immunoadsorption, etc.)
8.1.4.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Blood Purification Equipment Market, By Product
9.1. Blood Purification Equipment Market, by Product, 2023-2032
9.1.1. Portable
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Stationary
9.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Blood Purification Equipment Market, By Application
10.1. Blood Purification Equipment Market, by Application, 2023-2032
10.1.1. Acute Kidney Injury
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Infectious Diseases
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Sepsis
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Renal Diseases
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. COVID-19
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Blood Purification Equipment Market, By End User
11.1. Blood Purification Equipment Market, by End User, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Dialysis Centers
11.1.2.1. Market Revenue and Forecast (2021-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 12. Global Blood Purification Equipment Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2021-2032)
12.1.2. Market Revenue and Forecast, by Product (2021-2032)
12.1.3. Market Revenue and Forecast, by Application (2021-2032)
12.1.4. Market Revenue and Forecast, by End User (2021-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.1.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2021-2032)
12.1.6.2. Market Revenue and Forecast, by Product (2021-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2021-2032)
12.2.2. Market Revenue and Forecast, by Product (2021-2032)
12.2.3. Market Revenue and Forecast, by Application (2021-2032)
12.2.4. Market Revenue and Forecast, by End User (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.2.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2021-2032)
12.2.6.2. Market Revenue and Forecast, by Product (2021-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2021-2032)
12.2.7.2. Market Revenue and Forecast, by Product (2021-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2021-2032)
12.2.8.2. Market Revenue and Forecast, by Product (2021-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2021-2032)
12.3.2. Market Revenue and Forecast, by Product (2021-2032)
12.3.3. Market Revenue and Forecast, by Application (2021-2032)
12.3.4. Market Revenue and Forecast, by End User (2021-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.3.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2021-2032)
12.3.6.2. Market Revenue and Forecast, by Product (2021-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2021-2032)
12.3.7.2. Market Revenue and Forecast, by Product (2021-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2021-2032)
12.3.8.2. Market Revenue and Forecast, by Product (2021-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2021-2032)
12.4.2. Market Revenue and Forecast, by Product (2021-2032)
12.4.3. Market Revenue and Forecast, by Application (2021-2032)
12.4.4. Market Revenue and Forecast, by End User (2021-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.4.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2021-2032)
12.4.6.2. Market Revenue and Forecast, by Product (2021-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2021-2032)
12.4.7.2. Market Revenue and Forecast, by Product (2021-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2021-2032)
12.4.8.2. Market Revenue and Forecast, by Product (2021-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2021-2032)
12.5.5.2. Market Revenue and Forecast, by Product (2021-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2021-2032)
12.5.6.2. Market Revenue and Forecast, by Product (2021-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2032)
Chapter 13. Company Profiles
13.1. Cytosorbents Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Baxter International, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Cerus Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Jafron Biomedical Co., Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Spectra Medical, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. B. Braun Melsungen AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. and Nikkiso Co, Ltd
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. ExThera Medical Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Aethlon Medical, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Fresenius SE & Co. KGaA
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client